The Feinstein Institutes

One year since FDA approval- incredible results! A testament to the life work of Kevin J. Tracey. So proud to witness the ingenuity and dedication of the incredible teams at The Feinstein Institutes and SetPoint Medical. Everyone at Northwell Health is eager to see this improve the lives of so many suffering from RA. Also optimistic that this will soon prove to be equally beneficial in treating other inflammatory conditions.

A significant advance in pancreatic cancer treatment: the FDA has approved Rasonque (daraxonrasib), the first-in-class targeted therapy for adults with metastatic pancreatic adenocarcinoma who have received prior systemic therapy or are not candidates for multiagent systemic therapy. Daniel King, MD, PhD, director of research and development at the Northwell Cancer Institute's Center for Genomic Medicine says, "As an oncologist dedicated to pancreatic cancer care, I'm thrilled by the news: Daraxonrasib is now FDA approved! Showing a doubling of survival compared to chemo, this is an immense step forward. It reignites our hope and truly inspires us that our patients can live longer, fuller lives. This is a game-changer!" As assistant professor at the The Feinstein Institutes, Dr. King shares how powerful this is for patients. "This is why we fight every day – for more time, more life, and the belief that better treatments are not just possible, but here," says Dr. King. Learn more: https://bit.ly/4qGPNJJ

Thank you to ABC-7 New York and anchors Pedro Rivera, Shirleen Allicott, and Sam Champion for today's segment on the importance of perinatal mental health. Media coverage like this is essential for raising awareness, reducing stigma, and ensuring that families know effective treatments exist. As clinicians and researchers, we have a collective responsibility to advance both the science and the public conversation around perinatal mental health. Watch the segment here: https://lnkd.in/es7qH5eU #PerinatalMentalHealth #PostpartumDepression #MaternalMentalHealth abc7NY, Northwell Health, Katz Institute for Women's Health, The Feinstein Institutes

Northwell Health and Cold Spring Harbor Laboratory are proud to have helped lead an international research effort that developed more than 150 patient-derived cancer organoid models as part of the Human Cancer Model Initiative (HCMI). Published in Nature, the decade-long project resulted in 665 organoid models across 25 cancer types, now available to researchers worldwide. These next-generation models more closely reflect the biology of real patient tumors and may help accelerate discoveries in drug testing, tumor biology and more personalized cancer treatment strategies. This work highlights the power of collaboration across clinicians, scientists and patients and underscores how research partnerships can help move innovation from the lab toward better care. Read more: https://bit.ly/3RTWBH4

After wrapping up an incredible summer at The Feinstein Institutes, I’m extremely grateful for the opportunity to have worked alongside such an inspiring team and to continue contributing to our work remotely throughout the academic year. I’m especially thankful to Stavros Zanos for welcoming me into his lab and allowing me to learn, contribute, and grow as a researcher. Another special thank you to my fellow intern, Ella Kurtz, for making this summer such a fun and memorable one. I’m particularly grateful to Vasiliki Patsiou for being such an incredible mentor, for welcoming me into her project, and for trusting me to contribute to work that I learned so much from. Her guidance throughout the summer played a huge role in making this experience so impactful. I also want to thank Ishan Amin Khwaja, Naveen Jayaprakash, and Nicole Carpentiere for their support, mentorship, and the valuable insight they shared with me throughout the summer. This experience strengthened my appreciation for translational research and the incredible work that goes into connecting scientific discovery with improvements in patient care. I’m excited to stay involved with the team remotely and continue building on everything I learned this summer.